Ledger.Open graph →
SEC Form D · Amendment · filed April 8, 2016

Atrin Pharmaceuticals LLC

Offering
$2.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Bernard C. Rudnick · Doylestown, PAExec · DirectorOren Gilad · Doylestown, PAExec · Director · PromoterPeter J. Ogren · Burlington, MAExec · Director · PromoterCharles Smith · Denver, COExec · DirectorSusan D. Sarandon · New York, NYExec · DirectorLou D. Canakes Ii · New York, NYExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗